English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Medicines Agency
Erianne Leatherman
| Jun 6, 2017
Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Robert Hadley
| Apr 16, 2017
XGEVA pending approval for myeloma patients
Ruth de Jauregui
| Apr 9, 2017
Bruno Farmaceutici, Orexigen Therapeutics Ireland to distribute Mysimba in Italy
Ruth de Jauregui
| Apr 3, 2017
European Medicines Agency recommends Keytruda for approval
Ruth de Jauregui
| Apr 3, 2017
Inebilizumab receives orphan status from EMA for optic nerve disorder treatment
Robert Hadley
| Mar 30, 2017
Europe to evaluate antipsychotic drug for approval
Trending
Patient Daily
| Oct 9, 2025
Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+
Regulatory
Patient Daily
| Oct 14, 2025
Mackinac Center raises concerns over federal 340B drug pricing program’s market impact
Patient Daily
| Oct 9, 2025
AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+
Pharmaceuticals
Patient Daily
| Oct 13, 2025
Cardinal Institute policy analyst: 340B program 'has quietly become a $40B side business'
